SEC Form 4 · accession 0001493152-26-031377
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mahesh V. Patel
Officer — Chief Executive Officer · Director
Period of report
Jun 29, 2026
Accepted (ET)
Jun 30, 2026 · 7:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.49 | Jun 29, 2026 | A | 52,781 | A | Jun 29, 2027 | Jun 29, 2036 | Common Stock | 52,781 | 227,214 | D |
Explanation of responses
- F1Subject to vesting whereby 1/3 of the shares subject to the award will vest on June 29, 2027 while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.